Effects of TMPZ on LPS-induced cardiac cell damage and involved mechanism

Dan LIU,Dong YIN,Shu Zeng,Ming HE
DOI: https://doi.org/10.3969/j.issn.1001-1978.2012.11.012
2012-01-01
Abstract:Aim: To explore the role of tetramethylpyrazine (TMPZ) in lipopolysaccharide (LPS)-induced cardiac cell damage and the nuclear translocation of nuclear factor kappaB (NF-κB). Methods: Cardiac cells isolated from primary neonatal SD rat were pretreated with 40, 80, 120 μmol·L-1 TMPZ respectively, and then treated with 10 mg·L-1 LPS for 6 hours. After treatment, the activity of lactic acid dehydrogenase (LDH) was determined by auto-biochemistry analysator, cells viability was analyzed by methyl thiazolyl tetrazolium(MTT), generation of reactive oxygen species (ROS) were measured by flow cytometry, the content of malondialdehyde (MDA), and the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were analyzed by colori-metric method, the level of NF-κB p65 protein in nuclear was detected by western blotting. Results: 3 hours pretreatment with different doses of TMPZ (40, 80, 120 μmol·L-1) significantly increased cardiac cells viability, decreased LDH activity, ROS production and MAD content. SOD and GSH-Px activities were improved, and the nuclear expression of NF-κB p65 was inhibited in a dose-dependent manner. Conclusion: TMPZ can alleviate LPS-induced cardiac cell damage by suppressing lipid peroxidation, enhancing antioxidant enzymes, decreasing ROS production and inhibiting nuclear translocation of NF-κB.
What problem does this paper attempt to address?